Psyence Biomedical (PBM) Interest & Investment Income (2025)
Psyence Biomedical (PBM) recorded quarterly Interest & Investment Income of $103341.0 in Q3 2025.
Psyence Biomedical (PBM) Interest & Investment Income (2025) Analysis & Trends
Psyence Biomedical's Interest & Investment Income history runs 1 years deep, the most recent figure standing at $103341.0 for Q3 2025.
- In Q3 2025, Interest & Investment Income changed N/A year-over-year to $103341.0; the TTM figure through Sep 2025 stood at $103341.0 (changed N/A YoY), while the FY2025 annual figure was $95787.0, up 4388.61% from the prior year.
- Interest & Investment Income was $103341.0 for Q3 2025 at Psyence Biomedical.
- In the past five years, Interest & Investment Income ranged from a high of $103341.0 in Q3 2025 to a low of $103341.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 597,319.59 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -14.79 Mn |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 103,341.00 |